Healthcare utilization and disease burden in children with metachromatic leukodystrophy in Germany
Abstract Background Metachromatic leukodystrophy (MLD) is a life-limiting neurodegenerative disease due to pathogenic variants in the ARSA gene. Patients experience severe neurological symptoms, developmental regression, and early death. Aim of the study was to analyze disease burden and healthcare...
Saved in:
| Main Authors: | Christiane Kehrer, Andrea Bevot, Pascal Martin, Christa Raabe, Saskia Gregor, Ingeborg Krägeloh-Mann, Samuel Groeschel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03637-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lenmeldy (atidarsagene autotemcel) for individuals with early metachromatic leukodystrophy (MLD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
by: Rahaman Navaz Gangji, et al.
Published: (2025-01-01) -
Newborn Screening for Metachromatic Leukodystrophy in Tuscany: The Paradigm of a Successful Preventive Medicine Program
by: Sabrina Malvagia, et al.
Published: (2025-04-01) -
Metachromatic Leukodystrophy Presenting with Multiple Cranial Nerve and Lumbosacral Nerve Root Enhancement Without White Matter Changes
by: Ruben Jauregui, et al.
Published: (2025-02-01) -
From Clinical Presentation to Genetic Confirmation: A Case of L2HGDH-Related Leukodystrophy in an 11-Year-Old
by: Negareh Poursalehi, et al.
Published: (2025-03-01) -
The main forms of leukodystrophies. Lecture and clinical cases
by: A. A. Ershova, et al.
Published: (2023-12-01)